PASADENA, Calif., December 23, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-INHBE, the company ...
In recent years, the Chiefs have become the team to beat in the NFL, turning Arrowhead Stadium into the center of the football universe. The fourth-largest NFL stadium by capacity, Arrowhead ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.